TECNOTREE
23.2.2024 10:30:26 CET | Business Wire | Press release
Tecnotree, a global digital platform and services leader for AI, 5G, and cloud-native technologies, announced the simultaneous rollout of their digital BSS solutions for telecom service providers spanning across the Middle East and Africa. The milestone included 14 Go-lives globally for some of the largest Telecom, Healthcare and Realty groups across North America, the Middle East, Africa and Latam, delivering large-scale Digital BSS transformation for customers on public and private cloud through the Tecnotree Digital Suite (Tecnotree Edge).
The digital stack deployed under various transformation projects include Out of the Box capabilities of Tecnotree’s Digital Suite: Debt Management System, BSS-Switch with Convergent Online Charging System (COCS), Service Provisioning System (SPS), New Bill Layout Designer (BLD), Customer Lifecycle Manager (CLM), and more. By leveraging Tecnotree’s AI-powered, intelligent digital solutions, service providers will be able to align their capabilities with the evolving business needs. The comprehensive solutions will help deliver superior digital customer experience and transformation, introducing the next generation of services for their customers.
Tecnotree’s digital suite empowers robust capabilities for customer tracking across various channels, providing an enhanced 360-degree view of all interactions. This highly automated, full Digital stack, coupled with TMF Open API and ODA Compliant Architecture, facilitates faster service rollouts, ushering in new levels of agility and speed in an increasingly competitive and fast-paced market.
Padma Ravichander, CEO of Tecnotree Corporation said, “We take immense pride in the successful series of go-lives as they represent our unwavering focus on delivering large-scale digital transformation for our customers across various regions. We are enabling the next wave of digital transformation, aligning with the rapidly growing markets. The multiple and simultaneous go-lives speak to the predictability and stability of the Tecnotree Digital Stack in terms of its reliability, dynamic version upgrades, and autopilot capabilities.
With Tecnotree's comprehensive full-stack solution, operators can deliver new and innovative value-added services, unlocking new opportunities and revenue streams. The digital transformations will propel operational efficiencies for operators, enabling them to deliver personalized customer engagement while ensuring seamless and rapid upgrades of features. The offerings will be combined with deep insights in terms of customer experiences, with our embedded, augmented, and cognitive AI use cases on the stack.”
Ramaseshan Subramanian, Chief Delivery Officer, SVP Tecnotree said, “Overseeing the parallel launches of our cutting-edge digital BSS solutions for major telecom providers across the Middle East and Africa has been a testament to our commitment to provide the best-in-class delivery in an agile customer-success driven environment. Our accomplishment of orchestrating 14 successful go-lives for major operator groups worldwide represents a milestone in delivering extensive Digital BSS transformations through the Tecnotree Digital Suite, and further strengthens our commitment to enhance customer-centricity and operational efficiency.”
Shahbaz Ahmad Rashid, Head MEA & Europe, SVP Sales Tecnotree Corporation said, “We’re thrilled about the various successful go-lives which will accelerate digital transformation and deliver world-class experiences to our customers. With the intelligent, digital solutions from Tecnotree, these Opcos will be in a better position to meet the evolving needs of customers, while also accelerating sales, streamlining operations, and driving new monetization opportunities.”
About Tecnotree
Tecnotree is a 5G-ready digital Business Support System (BSS) player, with AI/ML capabilities and multi-cloud extensibility. Tecnotree leads the way on the TM Forum Open API Conformance with 59 certified Open APIs including 9 real-world open APIs, a testament to the company's commitment to excellence, and continuously striving to deliver differentiated experiences and services to both CSPs and DSPs. Our agile and open-source digital BSS Stack comprises the full range (order-to-cash) of business processes and subscription management for telecom and other digital services industries creating opportunities beyond connectivity. Tecnotree also provides Fintech and B2B2X multi-experience digital marketplace to its subscriber base through the Tecnotree Moments platform to empower digitally connected communities across gaming, health, education, OTT, and other vertical ecosystems. Tecnotree is listed on the Helsinki Nasdaq (TEM1V).
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240223931032/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Doubtless Pet Care Launches to Provide Peace of Mind to Pet Parents and Help Their Pets Live Happier, Healthier Lives29.6.2026 10:15:00 CEST | Press release
Doubtless combines industry-leading pet insurance with innovative care solutions, protecting more than 6 million pets across 10 global markets Doubtless launches today with the goal of helping more pet parents across the world access quality care for the pets they love. The company brings together a leading global portfolio of pet insurance brands with a growing range of connected solutions designed to support pet parents at every stage of their pet’s life. With over 4,000 employees, Doubtless insures 6 million pets across 10 markets in North America, Europe and the United Kingdom. “Uncertainty about the financial commitments associated with having a pet should never keep families from experiencing the joy of a life with pets,” said Dirk Beeckman, CEO of Doubtless. “By harnessing the power of our international footprint, we are building on our leadership in pet insurance to create a global suite of solutions for pet parents, veterinarians and industry partners that makes pet care easie
Samsung Bioepis Announces Positive Preliminary Phase 1 and Phase 3 Data for SB27, a Proposed Biosimilar to Keytruda (Pembrolizumab)29.6.2026 09:19:00 CEST | Press release
Phase 1 study demonstrated pharmacokinetic (PK) equivalence between SB27 and Keytruda; Phase 3 study demonstrated equivalent objective response rate (ORR) at Week 24Phase 1 and Phase 3 studies expected to be completed within 2026 Samsung Bioepis Co., Ltd. announced today that the Phase 1 and Phase 3 studies on SB27, a proposed biosimilar to Keytruda1 (pembrolizumab), have met their primary endpoints. “We are excited to announce preliminary results from the Phase 1 and Phase 3 studies for SB27, our pembrolizumab biosimilar candidate. These topline positive results reinforce our scientific expertise and leadership in biosimilar development,” said Donghoon Shin, Executive Vice President and Head of Clinical Sciences Division at Samsung Bioepis. “We are on track to complete both Phase 1 and Phase 3 studies within this year. Leveraging our robust quality management system, we remain committed to advancing our biosimilar portfolio to broaden access to life-saving biologic medicines for patie
IQM Named a Major Player in the IDC MarketScape: Worldwide Quantum Computing 2026 Vendor Assessment29.6.2026 09:00:00 CEST | Press release
IQM today announced it has been named a Major Player in the IDC MarketScape: Worldwide Quantum Computing 2026 Vendor Assessment. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260629748732/en/ IQM named a major player in the IDC MarketScape IQM believes this recognition comes as institutions worldwide move quantum computing out of shared cloud access and into infrastructure they own and operate themselves. IQM calls this Production Quantum: full-stack, open-architecture superconducting systems deployed on premises, inside customers' own data centers and HPC environments, where organizations own the hardware, build internal expertise, and run quantum processors alongside their existing classical infrastructure. According to the IDC MarketScape, "For institutions building long-term quantum programs, this means the workflows and intellectual property developed on IQM hardware remain portable." The report further advises: "Consi
Zambon Announces Positive CHMP Opinion for Hopledo® (IPX203) for Adults with Parkinson’s Disease and Moderate to Severe Motor Fluctuations29.6.2026 09:00:00 CEST | Press release
Positive CHMP opinion is based on data from the Phase 3 RISE-PD trial, which demonstrated significantly more “Good ON” time with fewer daily doses compared with immediate-release levodopa/carbidopa More than one million people are living with Parkinson’s disease in the European Union, and over 80% experience motor fluctuations during the course of their disease, highlighting the need for additional treatment options Hopledo® contains a unique formulation combining immediate-release granules and extended-release pellets, providing both a rapid onset of action and a longer duration of effect, sustaining the levodopa therapeutic effect for a longer period of time If approved, Zambon expects to make Hopledo® progressively available to patients with Parkinson’s disease across Europe starting October 2026 Zambon today announced that the Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the granting of a marketing authorization by the European M
Enhertu® Approved in the EU as First Tumor Agnostic HER2 Directed Therapy and Antibody Drug Conjugate for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors29.6.2026 08:30:00 CEST | Press release
Approval based on three phase 2 trials of Daiichi Sankyo and AstraZeneca’s Enhertu that demonstrated clinically meaningful responses across a broad range of tumors Enhertu now approved for six indications in the EU Enhertu® (trastuzumab deruxtecan) has been approved in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The approval by the European Commission follows the positive opinion of the Committee for Medicinal Products for Human Use of the European Medicines Agency and is based on results from subgroups of patients with HER2 positive (IHC 3+) tumors across thr
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom